Amantadine

Amantadine · AMANTADINE HYDROCHLORIDE 50 mg/5mL · Solution · Oral · AvPAK

NDC 50268-0036-14 · 40 TRAY in 1 CASE / 10 CUP, UNIT-DOSE in 1 TRAY / 10 mL in 1 CUP, UNIT-DOSE · ANDA · View full market →

The short version

Just 2 companies supply this market — thin enough that a single exit would be felt immediately.

The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.

Medicare Part D

No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.

How Part D pricing works →

NADAC price per unit

No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.

Supply fragility

Not scored — fragility is computed for NADAC-priced NDCs.

90-day shortage risk (model v2)

0.2%chance of a new FDA shortage posting for amantadine (other) in the next 90 days

OAI inspection at a producing facility (24 months) · sole-source market · price up 2% YoY

For scale: the typical drug’s chance is about 0.1% — this one is in ordinary territory.

Backtested statistical model over the whole market, not this package alone. Model details →

Regulatory

Application: ANDA075060
TE code: AA
Approval date: Dec 24, 1998
Patents / exclusivity: None on file

Shortage history

No FDA shortage reports for this drug or its presentations.

Recalls (this NDC)

No enforcement reports list this package NDC.

Manufacturers of Amantadine (Solution)

Labeler	Strength	First seen	Last seen
AvPAK	AMANTADINE HYDROCHLORIDE 50 mg/5mL	Jul 15, 2026	Sep 2, 2026
Xttrium Laboratories, Inc	AMANTADINE HYDROCHLORIDE 50 mg/5mL	Jul 15, 2026	Sep 2, 2026

Roster from daily NDC Directory diffs — first/last seen dates start July 2026.

Cite this page

DrugDashboards, "Amantadine — NDC 50268-0036-14," retrieved September 3, 2026, https://drugdashboards.com/drug/50268003614.

Free to cite with attribution — see how the data is put together.